<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>9</o:Revision>
  <o:TotalTime>196</o:TotalTime>
  <o:Created>2004-03-01T14:33:00Z</o:Created>
  <o:LastSaved>2004-03-01T19:07:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1160</o:Words>
  <o:Characters>6616</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>55</o:Lines>
  <o:Paragraphs>13</o:Paragraphs>
  <o:CharactersWithSpaces>8124</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:75.5pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:navy;
	font-weight:normal;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page2_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Calcium pumps<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Different forms, different functions<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Mammalian calcium
pumps are mainly located in either the plasma membrane, or in the internal
membranes of the sarcoplasmic or endoplasmic reticulum, and fall into three classes
of enzymes:<span style="mso-spacerun: yes">  </span>the plasma membrane calcium
ATPases (PMCA), which extrude calcium from the cell, the
sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA), which sequester
calcium within intracellular organelles, and the secretory pathway calcium
ATPases (SPCA), whose function is poorly understood.<span style="mso-spacerun:
yes">  </span>There are several genes encoding these different pumps, including
four PMCA pumps (PMCA1-4; in humans ATP2B1-4), three SERCA pumps (SERCA1-3; in
humans ATP2A1-3), and two putative SPCA pumps (SPCA1-2; in humans ATP2C1,
ATP2C4).<span style="mso-spacerun: yes">  </span>These genes can be
alternatively spliced, creating a total of more than 40 different splice variants,
each serving different biological and physiological functions. <span
style="mso-spacerun: yes"> </span></p>

<p class=MsoNormal style='tab-stops:75.5pt'><span style='mso-tab-count:1'>                         </span></p>

<h1><span lang=IT style='color:navy;mso-ansi-language:IT'>Plasma membrane
calcium ATPase (PMCA)<o:p></o:p></span></h1>

<p class=MsoNormal><span lang=IT style='mso-ansi-language:IT'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal><span lang=IT style='mso-ansi-language:IT'><span
style='mso-tab-count:1'>            </span></span>The basic function of the
plasma membrane calcium pumps are to maintain the 10,000-fold calcium gradient
across the plasma membrane via the highly regulated active expulsion of calcium
from the cell.<span style="mso-spacerun: yes">  </span>In addition, they are involved
in calcium signalling and the modulation of calcium spikes.<span
style="mso-spacerun: yes">  </span>PMCA isoforms can also have tissue-specific
roles, such as the regulation of the rate of clot retraction in platelets.<span
style="mso-spacerun: yes">  </span>There are more than 30 splice variants
formed from the four PMCA isoforms, each differing in its affinity for calcium
and <a href="http://www.ebi.ac.uk/interpro/potm/2003_3/Page_1.htm"
title="Protein of the month - CALMODULIN">calmodulin</a>, with some isoforms showing
tissue-specific expression.<span style="mso-spacerun: yes">  </span>For
instance, in rat brain, PMCA isoforms are differentially expressed within
different classes of neurons, suggesting that they play a complex role in
calcium homeostasis.<span style="mso-spacerun: yes">  </span>PMCA isoforms are
differentially regulated by protein kinases (PKA, PKC), by proteases (calpain),
by effector caspases, and by interaction with phospholipids (phosphotidylserine,
phosphatidylinositol), which act to shape the time course of the calcium
signals.<span style="mso-spacerun: yes">  </span>PMCAs can be distinguished
from SERCAs by the addition of an extended C-terminal tail that forms an
auto-inhibitory domain, providing a mechanism for regulation of PMCA activity
by cytosolic calcium concentration.<span style="mso-spacerun: yes">  </span>The
binding of calmodulin to this domain relieves the inhibition.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2>PMCA1</h2>

<p class=MsoNormal style='tab-stops:75.5pt'>PMCA1 is ubiquitously distributed
in tissues and cells, and is the most abundant isoform.<span
style="mso-spacerun: yes">  </span>c-Myb is known to repress PMCA1 expression
in vascular smooth cells.</p>

<p class=MsoNormal style='tab-stops:75.5pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2>PMCA2</h2>

<p class=MsoNormal style='tab-stops:75.5pt'>PMCA2 is mainly found in the central
nervous system, where it is the major isoform in purkinje neurons, as well as serving
organ-specific functions. <span style="mso-spacerun: yes"> </span>The PMCA2a isoform
is the only PMCA present in hair bundles, the sensory organelle of cochlear hair
cells of the inner ear that affect hearing and balance. Mice carrying mutations
in PMCA2 are profoundly deaf and have a balance defect due to the loss of PMCA2a
in sensory hair cells.</p>

<p class=MsoNormal style='tab-stops:75.5pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2>PMCA3 </h2>

<p class=MsoNormal style='tab-stops:75.5pt'>PMCA3 is mainly found in the central
nervous system, and was found at the highest levels in the cerebral cortex and
cerebellar cortex.</p>

<p class=MsoNormal style='tab-stops:75.5pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2>PMCA4</h2>

<p class=MsoNormal style='tab-stops:75.5pt'>PMCA4 is ubiquitously distributed
in tissues and cells, and constitutes 80% of PMCA in erythrocytes.<span
style="mso-spacerun: yes">  </span>Calcineurin was found to mediate the
repression of PMCA4 expression in neurons, thereby regulating cell cycle-associated
calcium concentration.<span style="mso-spacerun: yes">  </span>PMCA4b is the neuronal
nitric oxide synthase (nNOS)-associating isoform that helps to regulate
vascular tone by regulating intracellular calcium concentration.</p>

<p class=MsoNormal style='tab-stops:75.5pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Sarcoplasmic/endoplasmic reticulum calcium ATPase
(SERCA)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>The
endoplasmic reticulum (ER) plays an important role in regulating cytosolic
calcium levels through SERCA pumps, which accumulate calcium in the ER lumen. <span
style="mso-spacerun: yes"> </span>The mobilisation of calcium from
intracellular organelles is highly specialised in cardiac and skeletal muscle,
where SERCA makes up 90% of membrane proteins in the sarcoplasmic reticulum (SR)
of skeletal muscle.<span style='mso-ansi-language:EN-US'> <span
style="mso-spacerun: yes"> </span><span lang=EN-US>In skeletal muscle, calcium
ions are transported against a concentration gradient from the cytoplasm into
the SR, which causes the relaxation of muscle cells following the excitatory
effect of high cytosolic calcium.<span style="mso-spacerun: yes">  </span>In
cardiac muscle, the control of intracellular calcium is essential for the
regulation of cardiac contractility, and relies upon SERCA and PMCA pumps.</span></span><span
style="mso-spacerun: yes">  </span>SERCA pumps display greater homology with
sodium/potassium pumps, than with PMCA pumps, most differences occurring in the
transmembrane domain.<span style="mso-spacerun: yes">  </span>The three human SERCA
genes encode up to 10 isoforms by alternative splicing. </p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 style='tab-stops:36.0pt'>SERCA1</h2>

<p class=MsoNormal>The SERCA1 isoform is specific for the SR in fast-twitch skeletal
muscle.<span style="mso-spacerun: yes">  </span>There are at least two
C-terminal variants, both of which mediate the uptake of calcium into skeletal
muscle SR.<span style="mso-spacerun: yes">  </span>Autosomal recessive (loss of
function) mutations in SERCA1 are associated with Brody disease, a rare
inherited muscle disorder characterised by exercise-induced impairment of
skeletal muscle relaxation, resulting in stiffness and cramps.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 style='tab-stops:36.0pt'>SERCA2</h2>

<p class=MsoNormal>SERCA2 transports calcium from the cytosol into the ER lumen
to maintain low cytosolic calcium concentration.<span style="mso-spacerun:
yes">  </span>SERCA2 has been found in the SR of slow-twitch skeletal muscle,
as well as in other tissues.<span style="mso-spacerun: yes">  </span>The
SERCA2a isoform is expressed in the SR of cardiac muscle, where it plays a key
role in the contraction and relaxation of cardiac muscle through its control of
cytosolic calcium levels.<span style="mso-spacerun: yes">  </span>SERCA2a may
be involved in the pathogenesis of cardiac hypertrophy and failure.<span
style="mso-spacerun: yes">  </span>SERCA2a activity is regulated by phospholamban
and its homologue, sarcolipin, as well as by calcineurin.</p>

<p class=MsoNormal style='text-indent:36.0pt'>SERCA2b is the major isoform
expressed in smooth muscle and non-muscle tissues, such as the epidermis, where
it plays an important role in maintaining epidermal integrity.<span
style="mso-spacerun: yes">  </span>SERCA2b differs from SERCA2a at the
C-terminus, the extra sequences in SERCA2b containing an additional
transmembrane domain that interacts with calreticulin.<span
style="mso-spacerun: yes">  </span>Autosomal dominant mutations in SERCA2b are
associated with Darier disease, a skin disorder characterised by the loss of
adhesion between epidermal cells and abnormal keratinisation, as well as being associated
with a wide range of neuropsychiatric problems,<sup> </sup>such as epilepsy and
depression.<span style="mso-spacerun: yes">  </span>The presence of low lumenal
calcium concentrations in Darier disease patients could cause defective processing
of newly synthesised proteins required for normal adhesion between epithelial
cells.<span style="mso-spacerun: yes">  </span>SERCA2b also has a housekeeping
function that is critical for most mammalian cell types.</p>

<p class=MsoNormal style='text-indent:36.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 style='tab-stops:36.0pt'>SERCA3</h2>

<p class=MsoNormal>SERCA3 has three splice variants that vary in their C-termini.
<span style="mso-spacerun: yes"> </span>SERCA3 is expressed in many tissues,
and is often co-expressed with SERCA2b, yet unlike SERCA2b, SERCA3 does not
have an essential housekeeping function.<span style="mso-spacerun: yes"> 
</span>SERCA3 may be involved in the relaxation of vascular smooth muscle.<span
style="mso-spacerun: yes">  </span>SERCA3 may also play a role in regulating
insulin secretion via glucose-activated beta cell calcium signalling.<span
style="mso-spacerun: yes">  </span>Mutations in SERCA3 are thought to be
involved in non-insulin<sup> </sup>dependent type-II diabetes mellitus through
a pancreatic beta cell defect.<span style="mso-spacerun: yes">  </span>Abnormal
calcium concentrations are a common defect in both type I and II diabetes, effecting
beta cell function. </p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Secretory pathway calcium ATPase (SPCA)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span><span
style="mso-spacerun: yes"> </span>SPCA represents a third distinct type of
calcium pump.<span style="mso-spacerun: yes">  </span>The mammalian SPCA is
closely related to a prokaryotic calcium pump, PACL, cloned from
cyanobacterium.<span style="mso-spacerun: yes">  </span>As such, SPCA may
exhibit greater similarity to early eukaryotic calcium pumps than either PMCA
or SERCA.<span style="mso-spacerun: yes">  </span>Mutations in ATP2C1 (SPCA1)
are associated with the autosomal recessive Hailey-Hailey disease, where
abnormal calcium signalling in keratinocytes results in a blistering skin
disorder.<span style="mso-spacerun: yes">  </span>ATP2C1 is localised to the
Golgi apparatus in keratinocytes, where it controls Golgi calcium stores.<span
style="mso-spacerun: yes">  </span>Mutations in ATP2C1 may effect protein
sorting and maturation.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'><span style='font-weight:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page3.htm"
title="What InterPro tells us">What InterPro tells us</a><o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-weight:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page1.htm"
title="ATPase acts as a calcium pump">ATPase acts as a calcium pump</a><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
